ClinicalTrials.Veeva

Menu

Pecs Block vs Local Infiltration in Mastectomy (PBLIM)

H

Hasanuddin University

Status

Completed

Conditions

Pain, Postoperative

Treatments

Drug: LIA
Drug: PECS II block

Study type

Interventional

Funder types

Other

Identifiers

NCT06451705
173/UN4.6.4.5.31/PP36/2AZ4

Details and patient eligibility

About

Studied the comparison between PECS II block and LIA on pain intensity, opioid requirements, RNL, and postoperative IL-6 levels in MRM patients.

Enrollment

30 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age: 18-60 years old.
  2. Body weight (BW): 50-70 kg.
  3. Height (TB): 150-170 cm.
  4. Body mass index (BMI): 18.5-29.9 kg/m2.
  5. American Society of Anesthesiologists physical status (ASA PS) class I-II.
  6. Patients undergoing elective MRM surgery under general anesthesia.

Exclusion criteria

  1. Patients with contraindications to PECS II block.
  2. Patients with contraindications to LIA.
  3. Patients with coagulation disorders or receiving anticoagulant therapy.
  4. Patients with a history of chronic pain.
  5. Patients with a history of allergy to study materials.
  6. Patients with a history of previous breast surgery.
  7. Patient refuses to participate in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

PECS
Active Comparator group
Description:
PECS II block before surgery using isobaric bupivacaine 0.25% 20 mL (50 mg)
Treatment:
Drug: PECS II block
LIA
Active Comparator group
Description:
Local infiltration anesthesia after completion of surgery using isobaric bupivacaine 0.25% 20 mL (50 mg)
Treatment:
Drug: LIA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems